Loading…
Clinical and Molecular Features of Anti-CENP-B Autoantibodies
Centromeric proteins are the foundation for assembling the kinetochore, a macromolecular complex that is essential for accurate chromosome segregation during mitosis. Anti-centromere antibodies (ACAs) are polyclonal autoantibodies targeting centromeric proteins (CENP-A, CENP-B, CENP-C), predominantl...
Saved in:
Published in: | Journal of Molecular Pathology 2021-12, Vol.2 (4), p.281-295 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3 |
container_end_page | 295 |
container_issue | 4 |
container_start_page | 281 |
container_title | Journal of Molecular Pathology |
container_volume | 2 |
creator | Prasad, Rahul M. Bellacosa, Alfonso Yen, Tim J. |
description | Centromeric proteins are the foundation for assembling the kinetochore, a macromolecular complex that is essential for accurate chromosome segregation during mitosis. Anti-centromere antibodies (ACAs) are polyclonal autoantibodies targeting centromeric proteins (CENP-A, CENP-B, CENP-C), predominantly CENP-B, and are highly associated with rheumatologic disease (lcSSc/CREST syndrome). CENP-B autoantibodies have also been reported in cancer patients without symptoms of rheumatologic disease. The rise of oncoimmunotherapy stimulates inquiry into how and why anti-CENP-B autoantibodies are formed. In this review, we describe the clinical correlations between anti-CENP-B autoantibodies, rheumatologic disease, and cancer; the molecular features of CENP-B; possible explanations for autoantigenicity; and, finally, a possible mechanism for induction of autoantibody formation. |
doi_str_mv | 10.3390/jmp2040024 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8bb04d890a5543f89a7e83203097a7e1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8bb04d890a5543f89a7e83203097a7e1</doaj_id><sourcerecordid>2612792807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3</originalsourceid><addsrcrecordid>eNpNkEtPwzAQhC0EElXphV8QiRtSwK_4ceBQohYqlccBzpbt2ChRGhc7OfDvMRQBp51djWZHHwDnCF4RIuF1t9tjSCHE9AjMMOOkrDBDx__0KVik1MFsERUTjM7ATd23Q2t1X-ihKR5C7-zU61isnR6n6FIRfLEcxrasV4_P5W2xnMag825C07p0Bk687pNb_Mw5eF2vXur7cvt0t6mX29JiicbS2IYwJnljG8k9rLj1HmGEDCPYGYGYIQ5SYr2h2AvkqaHIGeIlh8JRqskcbA65TdCd2sd2p-OHCrpV34cQ35SOY2t7p4QxkDZCQl1VlHghNXeCYEig5FminHVxyNrH8D65NKouTHHI9VUmhLnEAvLsujy4bAwpRed_vyKovmirP9rkE0U-bys</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612792807</pqid></control><display><type>article</type><title>Clinical and Molecular Features of Anti-CENP-B Autoantibodies</title><source>Open Access: DOAJ - Directory of Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><creator>Prasad, Rahul M. ; Bellacosa, Alfonso ; Yen, Tim J.</creator><creatorcontrib>Prasad, Rahul M. ; Bellacosa, Alfonso ; Yen, Tim J.</creatorcontrib><description>Centromeric proteins are the foundation for assembling the kinetochore, a macromolecular complex that is essential for accurate chromosome segregation during mitosis. Anti-centromere antibodies (ACAs) are polyclonal autoantibodies targeting centromeric proteins (CENP-A, CENP-B, CENP-C), predominantly CENP-B, and are highly associated with rheumatologic disease (lcSSc/CREST syndrome). CENP-B autoantibodies have also been reported in cancer patients without symptoms of rheumatologic disease. The rise of oncoimmunotherapy stimulates inquiry into how and why anti-CENP-B autoantibodies are formed. In this review, we describe the clinical correlations between anti-CENP-B autoantibodies, rheumatologic disease, and cancer; the molecular features of CENP-B; possible explanations for autoantigenicity; and, finally, a possible mechanism for induction of autoantibody formation.</description><identifier>ISSN: 2673-5261</identifier><identifier>EISSN: 2673-5261</identifier><identifier>DOI: 10.3390/jmp2040024</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Antibodies ; Antigens ; Autoantibodies ; autoimmunity ; Breast cancer ; cancer ; Cell division ; CENP-B ; centromere ; Centromere protein A ; Chromosomes ; Crest syndrome ; Disease ; Lung cancer ; Macromolecules ; Medical diagnosis ; Mitosis ; Mutation ; Patients ; Proteins ; RNA polymerase ; Scleroderma</subject><ispartof>Journal of Molecular Pathology, 2021-12, Vol.2 (4), p.281-295</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3</citedby><cites>FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3</cites><orcidid>0000-0003-0636-9370</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2612792807/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2612792807?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,864,2102,25753,27924,27925,37012,44590,75126</link.rule.ids></links><search><creatorcontrib>Prasad, Rahul M.</creatorcontrib><creatorcontrib>Bellacosa, Alfonso</creatorcontrib><creatorcontrib>Yen, Tim J.</creatorcontrib><title>Clinical and Molecular Features of Anti-CENP-B Autoantibodies</title><title>Journal of Molecular Pathology</title><description>Centromeric proteins are the foundation for assembling the kinetochore, a macromolecular complex that is essential for accurate chromosome segregation during mitosis. Anti-centromere antibodies (ACAs) are polyclonal autoantibodies targeting centromeric proteins (CENP-A, CENP-B, CENP-C), predominantly CENP-B, and are highly associated with rheumatologic disease (lcSSc/CREST syndrome). CENP-B autoantibodies have also been reported in cancer patients without symptoms of rheumatologic disease. The rise of oncoimmunotherapy stimulates inquiry into how and why anti-CENP-B autoantibodies are formed. In this review, we describe the clinical correlations between anti-CENP-B autoantibodies, rheumatologic disease, and cancer; the molecular features of CENP-B; possible explanations for autoantigenicity; and, finally, a possible mechanism for induction of autoantibody formation.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Autoantibodies</subject><subject>autoimmunity</subject><subject>Breast cancer</subject><subject>cancer</subject><subject>Cell division</subject><subject>CENP-B</subject><subject>centromere</subject><subject>Centromere protein A</subject><subject>Chromosomes</subject><subject>Crest syndrome</subject><subject>Disease</subject><subject>Lung cancer</subject><subject>Macromolecules</subject><subject>Medical diagnosis</subject><subject>Mitosis</subject><subject>Mutation</subject><subject>Patients</subject><subject>Proteins</subject><subject>RNA polymerase</subject><subject>Scleroderma</subject><issn>2673-5261</issn><issn>2673-5261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpNkEtPwzAQhC0EElXphV8QiRtSwK_4ceBQohYqlccBzpbt2ChRGhc7OfDvMRQBp51djWZHHwDnCF4RIuF1t9tjSCHE9AjMMOOkrDBDx__0KVik1MFsERUTjM7ATd23Q2t1X-ihKR5C7-zU61isnR6n6FIRfLEcxrasV4_P5W2xnMag825C07p0Bk687pNb_Mw5eF2vXur7cvt0t6mX29JiicbS2IYwJnljG8k9rLj1HmGEDCPYGYGYIQ5SYr2h2AvkqaHIGeIlh8JRqskcbA65TdCd2sd2p-OHCrpV34cQ35SOY2t7p4QxkDZCQl1VlHghNXeCYEig5FminHVxyNrH8D65NKouTHHI9VUmhLnEAvLsujy4bAwpRed_vyKovmirP9rkE0U-bys</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Prasad, Rahul M.</creator><creator>Bellacosa, Alfonso</creator><creator>Yen, Tim J.</creator><general>MDPI AG</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0636-9370</orcidid></search><sort><creationdate>20211201</creationdate><title>Clinical and Molecular Features of Anti-CENP-B Autoantibodies</title><author>Prasad, Rahul M. ; Bellacosa, Alfonso ; Yen, Tim J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Autoantibodies</topic><topic>autoimmunity</topic><topic>Breast cancer</topic><topic>cancer</topic><topic>Cell division</topic><topic>CENP-B</topic><topic>centromere</topic><topic>Centromere protein A</topic><topic>Chromosomes</topic><topic>Crest syndrome</topic><topic>Disease</topic><topic>Lung cancer</topic><topic>Macromolecules</topic><topic>Medical diagnosis</topic><topic>Mitosis</topic><topic>Mutation</topic><topic>Patients</topic><topic>Proteins</topic><topic>RNA polymerase</topic><topic>Scleroderma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prasad, Rahul M.</creatorcontrib><creatorcontrib>Bellacosa, Alfonso</creatorcontrib><creatorcontrib>Yen, Tim J.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Journal of Molecular Pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prasad, Rahul M.</au><au>Bellacosa, Alfonso</au><au>Yen, Tim J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and Molecular Features of Anti-CENP-B Autoantibodies</atitle><jtitle>Journal of Molecular Pathology</jtitle><date>2021-12-01</date><risdate>2021</risdate><volume>2</volume><issue>4</issue><spage>281</spage><epage>295</epage><pages>281-295</pages><issn>2673-5261</issn><eissn>2673-5261</eissn><abstract>Centromeric proteins are the foundation for assembling the kinetochore, a macromolecular complex that is essential for accurate chromosome segregation during mitosis. Anti-centromere antibodies (ACAs) are polyclonal autoantibodies targeting centromeric proteins (CENP-A, CENP-B, CENP-C), predominantly CENP-B, and are highly associated with rheumatologic disease (lcSSc/CREST syndrome). CENP-B autoantibodies have also been reported in cancer patients without symptoms of rheumatologic disease. The rise of oncoimmunotherapy stimulates inquiry into how and why anti-CENP-B autoantibodies are formed. In this review, we describe the clinical correlations between anti-CENP-B autoantibodies, rheumatologic disease, and cancer; the molecular features of CENP-B; possible explanations for autoantigenicity; and, finally, a possible mechanism for induction of autoantibody formation.</abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/jmp2040024</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-0636-9370</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2673-5261 |
ispartof | Journal of Molecular Pathology, 2021-12, Vol.2 (4), p.281-295 |
issn | 2673-5261 2673-5261 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_8bb04d890a5543f89a7e83203097a7e1 |
source | Open Access: DOAJ - Directory of Open Access Journals; Publicly Available Content (ProQuest) |
subjects | Antibodies Antigens Autoantibodies autoimmunity Breast cancer cancer Cell division CENP-B centromere Centromere protein A Chromosomes Crest syndrome Disease Lung cancer Macromolecules Medical diagnosis Mitosis Mutation Patients Proteins RNA polymerase Scleroderma |
title | Clinical and Molecular Features of Anti-CENP-B Autoantibodies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A30%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20Molecular%20Features%20of%20Anti-CENP-B%20Autoantibodies&rft.jtitle=Journal%20of%20Molecular%20Pathology&rft.au=Prasad,%20Rahul%20M.&rft.date=2021-12-01&rft.volume=2&rft.issue=4&rft.spage=281&rft.epage=295&rft.pages=281-295&rft.issn=2673-5261&rft.eissn=2673-5261&rft_id=info:doi/10.3390/jmp2040024&rft_dat=%3Cproquest_doaj_%3E2612792807%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c291t-bcd36697dcd97f057cff1211b632eb816b3e043cfb42f81f4b41eb3f9708e44a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2612792807&rft_id=info:pmid/&rfr_iscdi=true |